| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |